GPT and metabolic dysfunction-associated steatotic liver disease: The liver enzyme of serum alanine aminotransferase (ALAT or ALT) could be used clinically as a screening tool for the detection of probable nonalcoholic fatty liver disease (NAFLD), potential liver dysfunction, viral hepatitis infection, hepatocellular damage, and infectious mononucleosis [1–7].